The exclusive license agreement permits Pharmanovia to launch catumaxomab, a unique trifunctional bi-specific monoclonal antibody, for intraperitoneal treatment of malignant ascites in EpCAM-positive carcinoma patients ineligible for additional...
The United States continues to be a crucial market for the Indian pharmaceutical industry, representing approximately 30% of overall sales and capturing a 40% share of the market in terms of volume. Despite possible risks from changes in duty...
There is a noticeable shift towards smart packaging technologies in the pharmaceutical blister packaging market. The trend of incorporating digital functions like tracking products using smartphones and reminding patients to take medication on...
China is upgrading its pharmaceutical industry to make drugs and healthcare more accessible. This is part of its plan to become more self-reliant through “new quality productive forces” driven by technical innovation and a supportive business...
Strengthening of Pharmaceutical Industry (SPI)' initiative, backed by Rs 500 crore (USD 60.9 million) provides vital support to enhance productivity, quality and sustainability across pharma clusters and MSMEs nationwide....
India holds the biggest share in global generic medicine supply with 20 percent, producing 60,000 generic brands in 60 therapeutic categories. Products made in the country are sent to more than 200 countries worldwide, with Japan, Australia...
The dialysis machines sector in India makes up around 3% of the Asia Pacific market, with the majority of machines being imported, leading to increased expenses. GlobalData reported that the market is expected to reach $14 million by 2033 due to...
Continuous innovation and biopharmaceutical research are driving growth in the specialty pharmaceutical market. The industry's dedication to creating innovative treatment choices plays a crucial role in achieving better disease targeting with...
The production facility of Lubrizol in India will expand its production of medical tubing by five times, improving availability of life-saving medical tubing locally and for global markets through exports. The collaboration will result in the...
Shanghai Pharmaceuticals is the biggest drug importer in China and the second largest distributor of pharmaceuticals. Shanghai Pharmaceuticals generates $37 billion in total revenue and produces medications for cancer, diabetes, cardiovascular...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")